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INTRODUCTION
The influence of permanent impairment of the respirato-
ry system is difficult to assess both objectively and reliably.
One rating guideline has been prepared by American Medi-
cal Association (AMA) (1), in which various respiratory dis-
eases are described, followed by objective examples for users.
An impairment rating guideline was prepared by the Min-
istry of Health and Welfare (MOHW) and is now being used
in Korea (2). However, it is based only on the parameters of
oxygen tension and forced expiratory volume in 1 second
(FEV1). To better evaluate the various kinds of respiratory
diseases that cause permanent impairment, more parame-
ters should be included, and a new impairment rating sys-
tem needs to be developed (3-5).
In the case of chronic obstructive pulmonary disease (CO-
PD), FEV1 and diffusion capacity are the most important
factors in an impairment rating, while forced vital capacity
(FVC) is the basis of the impairment assessment in restric-
tive pulmonary diseases. A typical symptom in respiratory
diseases is dyspnea, however, to objectively demonstrate it is
difficult in an impairment assessment. Additionally, the degree
of dyspnea and FEV1 shows no clear relationship (6).
As respiratory impairment is caused by various diseases
and situations, objectively scoring the degree of impairment
using only two indicators is difficult. Thus, this study was
conducted to make new objective and quantitative ratings
using multiple indicators to represent impairment in varied
respiratory diseases.
MATERIALS AND METHODS
Organizing committee on respiratory impairment 
The committee was supervised by Korean Academy of Med-
ical Sciences. The committee consisted of four members, three
recommended by Korean Academy of Tuberculosis and Res-
piratory Diseases, and one recommended Korean Society for
Thoracic and Cardiovascular Surgery. Each member had been
treating respiratory diseases for at least 15 yr and had expe-
riences in the determination of respiratory impairment.
Impairment grade determination guidelines
In determining the grade of impairment in a patient with
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Guideline of the Korean Academy of Medical Sciences for Assessing
Respiratory Impairment 
The presently used impairment rating guidelines in Korea do not accurately reflect
the injury in various lung diseases. Therefore, they need to be made more objective
and quantitative with new measurements, using indicators to more precisely repre-
sent impairment in the major respiratory diseases. We develop a respiratory impair-
ment rating guideline to ensure that the same grade or impairment rating would be
obtained regardless of surgeons who determinate it. Specialists in respiratory medicine
and thoracic surgeons determined the impairment grades. Moreover, the impair-
ment should be irreversible for more than 6 months. The impairment rating depends
on the level of forced vital capacity, forced expiratory volume 1 second, diffusion
capacity of carbon monoxide, arterial oxygen pressure, and arterial carbon dioxide
pressure. The degree of whole body impairment is defined by each grade: first 81-
95%, second 66-80%, third 51-65%, fourth 36-50%, and fifth 21-35%. In conclusion,
we develop a respiratory impairment rating guideline for Koreans. Any qualified spe-
cialist can easily use it and judge objective scoring. 
Key Words : Disability Evaluation; Respiratory System; Respiratory Function Tests 
Received : 27 February 2009
Accepted : 22 April 2009respiratory disease, the same grade or impairment rating
should result, regardless of which surgeon makes the deter-
mination. Thus, we established a rule that only objective
indicators would be used, excluding subjective symptoms.
Method of determining the impairment grade 
First, the various respiratory diseases that cause dyspnea
were divided into obstructive and restrictive pulmonary dis-
eases. Then, indicators were determined with which to judge
the degree of those conditions. 
RESULTS
Determinations of impairment grade 
The rating should be conducted at a time when the respi-
ratory impairment is permanent, following those guidelines.
First, the treatment term should be more than 6 months,
including the term of treatment in other hospitals. Second,
in cases of which pulmonary function changes, the 6-month
clock should be reset and treatment be continued. Here, a
‘‘change’’ in pulmonary function means over 12% increase
in FEV1 or more than 200 mL with a bronchodilator (7).
Third, if the impairment occurs as a result of thoracic trau-
ma or surgery, it should be observed for more than 1 yr to
determine whether the impairment is permanent. Typically,
respiratory medical specialists determine the impairment
grade; a thoracic surgeon should evaluate impairments occur-
ring after surgery or trauma.
Symptoms and impairment ratings
Symptoms and signs that could be used as parameters for
evaluating impairment include chest pain, chest wall defects
and deformities, a continuous thoracotomy catheter, dysp-
nea, and decline in exercise capacity. Dyspnea and decline in
exercise capacity are subjective concepts and are not suitable
as parameters, because of large differences among individuals.
Chest pain, chest wall defects and deformities, and a con-
tinuous thoracotomy catheter are used as parameters in the
impairment evaluation following thoracic trauma or surgery;
concrete guidelines are described below.
Chest pain evaluation after thoracic trauma or surgery should
satisfy the following conditions. First, the areas of thoracic
trauma or surgery and chest pain should be the same (e.g.,
areas of rib fractures confirmed by thoracic radiograph or bone
scan and the areas of thoracic surgery and chest pain should be
the same). Second, the pain should last longer than 6 months
after surgery or trauma. Third, the degree of pain should be
determined by insomnia or endless emotional pain because
of the chest pain, or the impossibility of performing the activi-
ties of everyday living (with concrete restrictions, such as an
inability to drive or do housework because of pain). Fourth,
patients should have taking non-narcotic or narcotic analgesics
to ease the pain for at least 6 months. Fifth, pain-related find-
ings should be observed on examination (clear expression of
aches or pain, such as a deep respiration moaning sound, exces-
sive self-protection, or a distorted face when being examined).
Tests used as impairment rating parameters
FVC, FEV1, diffusion capacity of carbon monoxide (DLCO),
arterial oxygen pressure (PaO2), and arterial carbon dioxide
pressure (PaCO2) should be determined by standard meth-
ods and measured when a patient is in a stable state.
Diseases needing impairment ratings and guidelines for
evaluating impairment
The core factors in respiratory disorders arise from deficits
in oxygen and carbon dioxide exchange in the alveolus. That
is, the most basic evaluation items are hypoxemia and hyper-
carbia, which can readily be evaluated by arterial blood gas
analysis. Ventilatory disorders, which are readily assessed using
ventilation-measuring pulmonary function tests such as spi-
rometry or flow-volume curves, can be subdivided into ob-
structive and restrictive disorders. Additionally, the diffusing
capacity of the lung, which generates dyspnea on exertion
with exercise-induced hypoxemia, should objectively be eval-
uated by DLCO measurements.
Evaluation of respiratory conditions in chronic diseases is
classified into physiological and functional aspects (Table 1).
They can be subdivided into obstructive ventilatory, restric-
tive ventilatory, hypoventilation, DLCO, and pulmonary
arterial hypertension impairments.
The test to quantitatively measure the degree of impair-
ment under each condition is shown in Table 2. The diagno-
sis of each disease is also outlined.
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Obstructive ventilation disorder 
Chronic airway disease; COPD, bronchial asthma, bronchiectasis
Large airway obstruction; tracheal neoplasm, vocal cord paralysis
Restrictive ventilation disorder
Interstitial lung disease; idiopathic pulmonary fibrosis
Chest wall disease; kyphoscoliosis, chest wall demormity
Pleural disease; fibrothorax
Hypoventilation disorder
Sleep-apnea syndrome; central or obstructive
Neuromuscular disease
Diffusion disorder
Interstitial lung disease, emphysema
Pulmonary hypertensive disorder
Primary pulmonary hypertension, chronic thromboembolic disaese
Table 1. Chronic respiratory diseases causing impairment 
COPD, chronic obstructive pulmonary disease.Determination of impairment rating
The impairment rating is to be determined by the most
severe clinical test results according to the guideline (Table
3). For example, a patient with COPD should be graded 2nd
impairment rating if the grade of FVC, FEV1, DLCO, and
PaO2 was 3rd, 3rd, 3rd, and 2nd, respectively. 
With chest pain, the grade is moved to the next high level
after satisfying the conditions. Only chest pain cannot be the
determinant of impairment grading. For example, the 3rd
grade impairment can upgrade to 2nd grade impairment if
severe chest pain persists after open thoracotomy. 
A patient who has been treated with a chest wall window
for cure of a deficit in the chest wall, a distorted chest, pleu-
ral emphysema, or bronchopleural fistula is moved to the third
grade. Such cases should be reevaluated annually and exclud-
ed from the impairment rating soon after the chest wall sutur-
ing reconstructive surgery is complete. 
A case with an indwelling catheter is rated as fourth grade,
and should also be reevaluated annually and excluded when
the tube is removed.
A considerable retraction or distortion occurring as a result
of multiple rib fractures is in the fifth grade. 
Degree of whole body impairment in each grade 
The degree of whole body impairment is defined by differ-
ences of 15% impairment between grades. Thus, the first
grade is 81-95%, the second is 66-80%, the third is 51-65%,
the fourth is 36-50%, and the fifth is 21-35%.
DISCUSSION 
We set out a respiratory impairment rating guideline for
Koreans, that relevant specialists can easily use, by removing
the effects of subjective judgments from impairment ratings.
The most important issue to consider at the time of deter-
mining the respiratory impairment is patient’s activity, estab-
lished by the degree of patient’s dyspnea. However, ‘‘dyspnea’’
is difficult to adequately define, although many have tried (8),
and it could be argued that none of them is accurate. Dysp-
nea is subjective, as experienced by patients. Accordingly,
dyspnea itself cannot be used to determine the impairment
grade. It may seem natural for dyspnea to be included in assess-
ing respiratory impairment, but it plays no part in this guide-
line for such determination.
It may also be argued that chest pain should be excluded
from the rating determination because the degree of chest
pain cannot be objectified. However, if the area of chest pain
corresponds to thoracic trauma, and radiological and objec-
tive evidence exists to take analgesics to ease the pain, then
chest pain is appropriately objective. Furthermore, chest pain
is not rated alone, but is included in the impairment rating.
The existing respiratory impairment guidelines consider
only FEV1 and PaO2 values. Thus, they give priority to chron-
ic obstructive pulmonary disease, which is a weakness, because
the guidelines do not adequately deal with impairment caused
by other major chronic respiratory conditions such as inter-
stitial lung disease, thorax and pleural diseases, and surgical
lung resection. 
The existing guidelines could be improved by including
physiological impairment in patients with interstitial lung
disease and emphysema, and by adding the FVC test to rate
restrictive pulmonary function impairment, and the DLCO
test to rate the exercise-induced hypoxemia. In our guidelines,
DLCO was included, whereas DLCO/VA was excluded from
the lost part of the lung parenchyma by lung resection and
lung parenchymal destruction. A PaCO2 test was added to
rate ventilatory defects and physiological impairment caused
by pulmonary hypertension. With the additional tests, the
new guidelines reflect pathophysiological traits of various
major chronic respiratory diseases that can cause respiratory
impairment.
As previously stated, FEV1 is representative of the degree of
impairment in the case of obstructive lung disease, however,
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*, denotes arterial blood gas analysis.
FEV1, forced expiratory volume 1 second; DLCO, diffusion capacity of
carbon monoxide; CT, computed tomography; PaO2, arterial oxygen
pressure; PaCO2, arterial carbon dioxide pressure; FVC, forced vital
capacity.
FVC, forced vital capacity; FEV1, forced expiratory volume 1 second;
DLCO, diffusion capacity of carbon monoxide; PaO2, arterial oxygen
pressure; PaCO2, arterial carbon dioxide pressure.
Classification Tests for diagnosis
Tests for impair-
ment grading
Ventilatory Chest roentgenogram, ABGA* FEV1, DLCO
disorder Chest CT scan, spirometry PaO2, PaCO2
Restrictive Chest roentgenogram, ABGA FVC, DLCO
disorder Chest CT scan, spirometry, PaO2
lung biopsy
Pulmonary Echocardiogram, chest CT scan, PaO2
hypertension cardiac catheterization
Hypoventilation Neuromuscular test FVC, FEV1,
disorder PaCO2




5th 4th 3rd 2nd  1st 
FVC (%) ≥61 - 51-60 41-50 36-40 ≤35
FEV1 (%) >61 51-60 41-50 31-40 26-30 <25
DLCO (%) >61 -- 51-60 41-50 <40
PaO2 (mmHg) ≥66 -- 61-65 56-60 ≤55
PaCO2 (mmHg) ≤44 -- 45-50 51-59 ≥60
Table 3. Impairment grading according to clinical parametersit is not completely objective. However, FEV1 is still used
because it is probably the best test available. When applied
to some patients (that is, a score below 27), the impairment
degree should be upgraded by one grade (data not shown). 
Regarding restrictive lung disease, it can be argued that the
value of diffusing capacity of the lungs used to determine im-
pairment should be adjusted higher or lower than the value
proposed here. For the impairment rating guideline to be ap-
plied reliably in the clinic, the values stated here should be used.
The final impairment rating by our guideline is determined
by the lowest (most severe) rating among the five rating items.
This is because impairment should not be determined by
only one factor of respiratory disease. For example, in patients
with serious emphysema, they often complain of dyspnea,
but the condition might not be considered as one of impair-
ment by only DLCO. Furthermore, the arterial blood gas test
or FEV1 findings may not fit the rating guidelines for seri-
ous impairment, and DLCO might have been reduced. For
patients with idiopathic pulmonary fibrosis, the arterial blood
gas test or FEV1 may suggest no impairment rating based
on spirometry findings. However, in such cases, DLCO will
likely be considerably reduced, so that it can be the prime
determinant of the impairment rating. In patients with pul-
monary hypertension and clearly increased PaCO2, this test
alone can be used to make the determination of impairment. 
We propose that impairment determinations should be
made by specialists in departments of respiratory and tho-
racic surgery. However, some patients with asthma whose
disease does not respond to respiratory relaxants may be treat-
ed at a COPD clinic. Thus, specialists in allergy departments
treating patients with asthma should perhaps also be includ-
ed to the list of practitioners who make impairment deter-
minations. 
The rating guideline for the disabled which was prepared
by the AMA includes impairment guidelines fitted to each
disease by defining diseases and describing diagnosis meth-
ods for each (1). Accordingly, the grade is determined for each
disease, and for airway disease, it is determined by the find-
ings of pulmonary function tests. Of course, it would be ideal
to define every disease and to set up the diagnosing methods
and guidelines for grading impairments, nevertheless, it is
too early to do so for many diseases in an economically effec-
tive manner.
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